Skip to content

Evaluation of the Influence of Aromatherapy and Music Therapy on Stress During the Management of Cerebral Arteriography

Evaluation of the Influence of Aromatherapy and Music Therapy on Stress During the Management of Cerebral Arteriography

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06425237
Acronym
HERMES
Enrollment
224
Registered
2024-05-22
Start date
2024-11-04
Completion date
2027-11-04
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Scheduled for Cerebral Arteriography for Diagnostic or Therapeutic Purposes

Brief summary

Cerebral arteriography is a reference examination in medical imaging. This examination is performed to allow the diagnosis and therapeutic management of patients with vascular pathologies. It is most often accompanied by a situation of stress, anxiety and apprehension related to the course of the examination or the announcement of the results. These situations generate physiological reactions in patients, making the performance of cerebral arteriography more complex. In order to improve the quality of care for patients undergoing this invasive examination, it is proposed to use two non-medicinal techniques known for their soothing and relaxing properties: aromatherapy and music therapy alone or in combination. These two techniques will help to establish a common thread from the preparation of the patient before the examination to his return to the post-interventional surveillance room.

Interventions

OTHERmusic therapy

standard patient care in interventional radiology associated with a well-being atmosphere with the implementation of music therapy (soothing sound environment) in the preparation box and in the examination room.

OTHERaromatherapy

standard patient care in interventional radiology associated with a well being atmosphere with the implementation of aromatherapy (essential oil of Ylang Ylang) in the preparation box and in the examination room.

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (≥ 18 years old) * Patient who is scheduled for a cerebral arteriography with local anaesthesia * Patient who capable to read and understand the patient information and consent. * Patient capable to read and sign the consent form * Patient with social insurance * Woman of childbearing age with effective contraception (see WHO definition), postmenopausal woman (≥ 12 months of amenorrhea not induced by therapy) * Negative urine pregnancy test

Exclusion criteria

* Patients who have had a previous cerebral arteriogram * Patient with allergy to iodinated contrast medium * Patient with severe renal insufficiency * Patient requiring sedation and artificial ventilation * Patient who is deaf and/or hard of hearing * Patient with a known allergy to essential oils * Patient with anosmia * Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection, under guardianship or curatorship, * Pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frameDescription
influence of aromatherapy and music therapy on the patient's stress when undergoing cerebral arteriography.day 1blood pressure

Secondary

MeasureTime frameDescription
stressday 1scale :0 : no stress to 10 : a lot of stress
level of painday 1scale : 0 : no pain to 10 : unbearable pain
hospital anxiety and depression scaleday 1scale : 0 to 7: no anxiety no depressed and 7 to 10 : probably anxiety ans drepressed more than and 10 : symptomatology of anxiety and depressed
Cumulative X-ray dose (mGy/cm2) received by the patientday 1

Countries

France

Contacts

CONTACTMagali DUVAL, radiology technician
magali.duval@chu-rouen.fr+33 2 32 88 83 83
CONTACTDéborah LEBEDIEFF
deborah.lebedieff@chu-rouen.fr+33 2 32 88 89 90
PRINCIPAL_INVESTIGATORMagali DUVAL, radiology technician

CHU Rouen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026